Eficacia terapéutica y seguridad del tocilizumab en COVID-19

Di Líbero, Eugenia; Osuna, Carolina; Gañete, Marcelo.
Actual. SIDA. infectol ; 30(108): 42-58, 20220000. tab, fig
Artigo em Espanhol | LILACS, BINACIS | ID: biblio-1363401

Similares

  1. Human Antibodies for Viral Infections.
  2. IL-6 Revisited: From Rheumatoid Arthritis to CAR T Cell Therapy and COVID-19.
  3. Haunting innate immune memories of COVID-19.
  4. Host Recovery from Respiratory Viral Infection.
  5. Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States.
  6. Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States.
  7. Defining the role of natural killer cells in COVID-19.
  8. Epigenetic memory of coronavirus infection in innate immune cells and their progenitors.
  9. The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection.
  10. The WHO estimates of excess mortality associated with the COVID-19 pandemic.